The collaboration will initially focus on two research programs. The first is a study on insulin resistant patients with a family history of type 2 diabetes. The primary objective is to identify predictive markers of disease that can be translated into blood based diagnostics. The second study will focus on understanding the effects of gastric bypass surgery on insulin sensitivity.
Lipomics will retain certain rights to develop diagnostic applications based on data emerging from these studies. Lipomics is developing diagnostic monitoring tools for the management of type 2 diabetes.